Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox versus placebo for gait disorder due to spastic equinovarus foot
2005-004685-17Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in Spastic Foot (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Effect on calf spasticity, Temporospatial gait parameters and 2 more. Started Jan 2006; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Spastic Foot
Beyond the preview
Go deeper on 2005-004685-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004685-17.